Related Experiment Videos
Intrathyroid parathyroid gland and neonatal primary hyperparathyroidism.
J E Janik1, C A Bloch, J S Janik
1Department of Pediatric Surgery, The Children's Hospital, University of Colorado Health Sciences Center, Denver, USA.
Journal of Pediatric Surgery
|October 29, 2000
Summary
Neonatal hyperparathyroidism (NPHP), a rare condition, can be treated with parathyroidectomy. This case shows successful surgical management leading to normal development and calcium levels.
Area of Science:
- Pediatric Endocrinology
- Genetics
- Surgical Innovation
Background:
- Neonatal hyperparathyroidism (NPHP) is a rare and often fatal endocrine disorder.
- Characterized by severe hypercalcemia in newborns, NPHP requires prompt diagnosis and management.
- Familial hypocalciuric hypercalcemia (FHH) is a genetic condition affecting calcium regulation.
Observation:
- A neonate presented with extremely high serum calcium (33 mg/dL).
- The patient had an unusually located parathyroid gland within the thyroid gland.
- A family history of hypocalciuric hypercalcemia (FHH) was noted.
Findings:
- Successful total parathyroidectomy was performed.
- The child achieved normocalcemia and normal development post-surgery.
- Long-term management included calcium and calcitriol replacement therapy.
Implications:
- This case supports the link between NPHP and parathyroid hyperplasia.
- It suggests NPHP and FHH may exist on a disease continuum.
- Highlights the potential efficacy of surgical intervention for severe NPHP.